Skip to main content
Top
Published in: Journal of Gastroenterology 8/2010

01-08-2010 | Original Article—Alimentary Tract

Effects of lansoprazole on the expression of VEGF and cellular proliferation in a rat model of acetic acid-induced gastric ulcer

Authors: Shun Kobayashi, Noriko Nakajima, Yoko Ito, Mitsuhiko Moriyama

Published in: Journal of Gastroenterology | Issue 8/2010

Login to get access

Abstract

Background

A recent study reported that in addition to their inhibitory effect on gastric acid secretion, some proton pump inhibitors also exert a cytoprotective effect on the gastric mucosa. We investigated the effects of lansoprazole (LPZ) on the epithelial cell cycle, and on the expressions of vascular endothelial growth factor (VEGF) and matrix metalloproteinase-2 (MMP-2).

Methods

We examined the effects of 25 and 5 mg/kg LPZ on ulcer healing in an acetic acid-induced ulcer model in rats with and without indomethacin (IND) treatment. On days 14 and 28 after ulcer formation, we compared the ulcer diameter, bromodeoxyuridine (BrdU) uptake, apoptosis, vascular density, and the expressions of VEGF and MMP-2 in the different groups.

Results

LPZ administration increased the BrdU uptake that was reduced by IND administration. LPZ administration also increased VEGF expression at the ulcer margin in a dose-dependent manner. However, LPZ administration did not increase VEGF expression following IND pretreatment. Administration of IND alone significantly decreased MMP-2 expression at the ulcer margin; on the other hand, subsequent administration of LPZ increased the MMP-2 expression.

Conclusion

One of the mechanisms of ulcer healing brought about by LPZ may be the involvement of endogenous prostaglandin (PG) secretion. The effect of endogenous PG secretion may be related to the induction of VEGF expression. On the other hand, LPZ administration increased MMP-2 expression, and this effect was not influenced by the inhibition of PG synthesis. The mechanisms of LPZ on ulcer healing may be involved by VEGF expression through endogenous PGs secretion. Additionally, the stimulated expression of MMP-2, which is not secreted by endogenous PGs, is another important factor for ulcer healing by LPZ.
Literature
1.
go back to reference Satoh H, Inatomi N, Nagaya H, Inada I, Nohara A, Nakamura N, et al. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats. J Pharmacol Exp Ther. 1989;248:806–15.PubMed Satoh H, Inatomi N, Nagaya H, Inada I, Nohara A, Nakamura N, et al. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats. J Pharmacol Exp Ther. 1989;248:806–15.PubMed
2.
go back to reference Nagaya H, Satoh H, Maki Y. Possible mechanism for the inhibition of acid formation by the proton pump inhibitor AG-1749 in isolated canine parietal cells. J Pharmacol Exp Ther. 1990;252:1289–95.PubMed Nagaya H, Satoh H, Maki Y. Possible mechanism for the inhibition of acid formation by the proton pump inhibitor AG-1749 in isolated canine parietal cells. J Pharmacol Exp Ther. 1990;252:1289–95.PubMed
3.
go back to reference Capodicasa E, De Bellis F, Pelli MA. Effect of lansoprazole on human leukocyte function. Immunopharmacol Immunotoxicol. 1999;21:357–77.CrossRefPubMed Capodicasa E, De Bellis F, Pelli MA. Effect of lansoprazole on human leukocyte function. Immunopharmacol Immunotoxicol. 1999;21:357–77.CrossRefPubMed
4.
go back to reference Inada I, Satoh H. Capsaicin-sensitive sensory neurons are involved in bicarbonate secretion induced by lansoprazole, a proton pump inhibitor, in rats. Dig Dis Sci. 1996;41:785–90.CrossRefPubMed Inada I, Satoh H. Capsaicin-sensitive sensory neurons are involved in bicarbonate secretion induced by lansoprazole, a proton pump inhibitor, in rats. Dig Dis Sci. 1996;41:785–90.CrossRefPubMed
5.
go back to reference Asaki S, Sato A, Sakurada H, Takeda T, Hongo M, Toyota T. Clinical evaluation of lansoprazole in the treatment of peptic ulcers: initial healing and prevention of relapse. Tohoku Peptic Ulcer Study Group. J Clin Gastroenterol. 1995;20(Suppl 2):S56–8.CrossRefPubMed Asaki S, Sato A, Sakurada H, Takeda T, Hongo M, Toyota T. Clinical evaluation of lansoprazole in the treatment of peptic ulcers: initial healing and prevention of relapse. Tohoku Peptic Ulcer Study Group. J Clin Gastroenterol. 1995;20(Suppl 2):S56–8.CrossRefPubMed
6.
go back to reference Tsuji S, Sun WH, Tsujii M, Kawai N, Kimura A, Kakiuchi Y, et al. Lansoprazole induces mucosal protection through gastrin receptor-dependent up-regulation of cyclooxygenase-2 in rats. J Pharmacol Exp Ther. 2002;303:1301–8.CrossRefPubMed Tsuji S, Sun WH, Tsujii M, Kawai N, Kimura A, Kakiuchi Y, et al. Lansoprazole induces mucosal protection through gastrin receptor-dependent up-regulation of cyclooxygenase-2 in rats. J Pharmacol Exp Ther. 2002;303:1301–8.CrossRefPubMed
7.
go back to reference Konturek SJ, Brzozowski T, Radecki T. Protective action of omeprazole, a benzimidazole derivative, on gastric mucosal damage by aspirin and ethanol in rats. Digestion. 1983;27:159–64.CrossRefPubMed Konturek SJ, Brzozowski T, Radecki T. Protective action of omeprazole, a benzimidazole derivative, on gastric mucosal damage by aspirin and ethanol in rats. Digestion. 1983;27:159–64.CrossRefPubMed
8.
go back to reference Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997;18:4–25.CrossRefPubMed Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997;18:4–25.CrossRefPubMed
9.
go back to reference Jones MK, Kawanaka H, Baatar D, Szabo IL, Tsugawa K, Pai R, et al. Gene therapy for gastric ulcers with single local injection of naked DNA encoding VEGF and angiopoietin-1. Gastroenterology. 2001;121:1040–7.CrossRefPubMed Jones MK, Kawanaka H, Baatar D, Szabo IL, Tsugawa K, Pai R, et al. Gene therapy for gastric ulcers with single local injection of naked DNA encoding VEGF and angiopoietin-1. Gastroenterology. 2001;121:1040–7.CrossRefPubMed
10.
go back to reference Shahin M, Konturek JW, Pohle T, Schuppan D, Herbst H, Domschke W. Remodeling of extracellular matrix in gastric ulceration. Microsc Res Tech. 2001;53:396–408.CrossRefPubMed Shahin M, Konturek JW, Pohle T, Schuppan D, Herbst H, Domschke W. Remodeling of extracellular matrix in gastric ulceration. Microsc Res Tech. 2001;53:396–408.CrossRefPubMed
11.
go back to reference Swarnakar S, Ganguly K, Kundu P, Banerjee A, Maity P, Sharma AV. Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer. J Biol Chem. 2005;280:9409–15.CrossRefPubMed Swarnakar S, Ganguly K, Kundu P, Banerjee A, Maity P, Sharma AV. Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer. J Biol Chem. 2005;280:9409–15.CrossRefPubMed
12.
go back to reference Ito A, Nagase H, Mori Y. Characterization of metalloproteinases in rat gastric tissues with acetic acid-induced ulcers. Scand J Gastroenterol Suppl. 1989;162:146–9.CrossRefPubMed Ito A, Nagase H, Mori Y. Characterization of metalloproteinases in rat gastric tissues with acetic acid-induced ulcers. Scand J Gastroenterol Suppl. 1989;162:146–9.CrossRefPubMed
13.
go back to reference Okabe S, Amagase K. An overview of acetic acid ulcer models—the history and state of the art of peptic ulcer research. Biol Pharm Bull. 2005;28:1321–41.CrossRefPubMed Okabe S, Amagase K. An overview of acetic acid ulcer models—the history and state of the art of peptic ulcer research. Biol Pharm Bull. 2005;28:1321–41.CrossRefPubMed
14.
go back to reference Blandizzi C, Fornai M, Colucci R, Natale G, Lubrano V, Vassalle C, et al. Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage. World J Gastroenterol. 2005;11:4052–60.PubMed Blandizzi C, Fornai M, Colucci R, Natale G, Lubrano V, Vassalle C, et al. Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage. World J Gastroenterol. 2005;11:4052–60.PubMed
15.
go back to reference Konturek SJ, Konturek PC, Brzozowski T. Prostaglandins and ulcer healing. J Physiol Pharmacol. 2005;56(Suppl 5):5–31. Konturek SJ, Konturek PC, Brzozowski T. Prostaglandins and ulcer healing. J Physiol Pharmacol. 2005;56(Suppl 5):5–31.
16.
go back to reference Levi S, Goodlad RA, Lee CY, Stamp G, Walport MJ, Wright NA, et al. Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet. 1990;336:840–3.CrossRefPubMed Levi S, Goodlad RA, Lee CY, Stamp G, Walport MJ, Wright NA, et al. Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet. 1990;336:840–3.CrossRefPubMed
17.
go back to reference Li X, Traganos F, Melamed MR, Darzynkiewicz Z. Single-step procedure for labeling DNA strand breaks with fluorescein- or BODIPY-conjugated deoxynucleotides: detection of apoptosis and bromodeoxyuridine incorporation. Cytometry. 1995;20:172–80.CrossRefPubMed Li X, Traganos F, Melamed MR, Darzynkiewicz Z. Single-step procedure for labeling DNA strand breaks with fluorescein- or BODIPY-conjugated deoxynucleotides: detection of apoptosis and bromodeoxyuridine incorporation. Cytometry. 1995;20:172–80.CrossRefPubMed
18.
go back to reference Yokoyama K, Nakajima N, Ito Y, Iwasaki A, Arakawa Y. Histoimmunological evaluation for the efficacy of entero nutrient containing n-3 fatty acid in TNBS rat colitis model. J Clin Biochem Nutr. 2006;9:88–97.CrossRef Yokoyama K, Nakajima N, Ito Y, Iwasaki A, Arakawa Y. Histoimmunological evaluation for the efficacy of entero nutrient containing n-3 fatty acid in TNBS rat colitis model. J Clin Biochem Nutr. 2006;9:88–97.CrossRef
19.
go back to reference Tanigawa T, Watanabe T, Higuchi K, Machida H, Okazaki H, Yamagami H, et al. Lansoprazole, a proton pump inhibitor, suppresses production of tumor necrosis factor-alpha and interleukin-1 beta induced by lipopolysaccharide and Helicobacter pylori bacterial components in human monocytic cells via inhibition of activation of nuclear factor-kappaB and extracellular signal-regulated kinase. J Clin Biochem Nutr. 2009;45:86–92.CrossRefPubMed Tanigawa T, Watanabe T, Higuchi K, Machida H, Okazaki H, Yamagami H, et al. Lansoprazole, a proton pump inhibitor, suppresses production of tumor necrosis factor-alpha and interleukin-1 beta induced by lipopolysaccharide and Helicobacter pylori bacterial components in human monocytic cells via inhibition of activation of nuclear factor-kappaB and extracellular signal-regulated kinase. J Clin Biochem Nutr. 2009;45:86–92.CrossRefPubMed
20.
go back to reference Takagi T, Naito Y, Okada H, Ishii T, Mizushima K, Akagiri S, et al. Lansoprazole, a proton pump inhibitor, mediates anti-inflammatory effect in gastric mucosal cells through the induction of heme oxygenase-1 via activation of NF-E2-related factor 2 and oxidation of kelch-like ECH-associating protein 1. J Pharmacol Exp Ther. 2009;331:255–64.CrossRefPubMed Takagi T, Naito Y, Okada H, Ishii T, Mizushima K, Akagiri S, et al. Lansoprazole, a proton pump inhibitor, mediates anti-inflammatory effect in gastric mucosal cells through the induction of heme oxygenase-1 via activation of NF-E2-related factor 2 and oxidation of kelch-like ECH-associating protein 1. J Pharmacol Exp Ther. 2009;331:255–64.CrossRefPubMed
21.
go back to reference Laine L, Takeuchi K, Tarnawski A. Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology. 2008;135:41–60.CrossRefPubMed Laine L, Takeuchi K, Tarnawski A. Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology. 2008;135:41–60.CrossRefPubMed
22.
go back to reference Shweiki D, Itin A, Neufeld G, Gitay-Goren H, Keshet E. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest. 1993;91:2235–43.CrossRefPubMed Shweiki D, Itin A, Neufeld G, Gitay-Goren H, Keshet E. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest. 1993;91:2235–43.CrossRefPubMed
23.
go back to reference Hatazawa R, Tanaka A, Tanigami M, Amagase K, Kato S, Ashida Y, et al. Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors. Am J Physiol Gastrointest Liver Physiol. 2007;293:G788–97.CrossRefPubMed Hatazawa R, Tanaka A, Tanigami M, Amagase K, Kato S, Ashida Y, et al. Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors. Am J Physiol Gastrointest Liver Physiol. 2007;293:G788–97.CrossRefPubMed
24.
go back to reference Wallace JL, Dicay M, McKnight W, Dudar GK. Platelets accelerate gastric ulcer healing through presentation of vascular endothelial growth factor. Br J Pharmacol. 2006;148:274–8.CrossRefPubMed Wallace JL, Dicay M, McKnight W, Dudar GK. Platelets accelerate gastric ulcer healing through presentation of vascular endothelial growth factor. Br J Pharmacol. 2006;148:274–8.CrossRefPubMed
25.
go back to reference Majima M, Hayashi I, Muramatsu M, Katada J, Yamashina S, Katori M. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Br J Pharmacol. 2000;130:641–9.CrossRefPubMed Majima M, Hayashi I, Muramatsu M, Katada J, Yamashina S, Katori M. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Br J Pharmacol. 2000;130:641–9.CrossRefPubMed
26.
go back to reference Fu S, Ramanujam KS, Wong A, Fantry GT, Drachenberg CB, James SP, et al. Increased expression and cellular localization of inducible nitric oxide syntheses and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology. 1999;116:1319–29.CrossRefPubMed Fu S, Ramanujam KS, Wong A, Fantry GT, Drachenberg CB, James SP, et al. Increased expression and cellular localization of inducible nitric oxide syntheses and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology. 1999;116:1319–29.CrossRefPubMed
27.
go back to reference Tanaka A, Hase S, Miyazawa T, Takeuchi K. Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: a key to nonsteroidal anti-inflammatory drug-induced intestinal damage. J Pharmacol Exp Ther. 2001;300:754–60.CrossRef Tanaka A, Hase S, Miyazawa T, Takeuchi K. Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: a key to nonsteroidal anti-inflammatory drug-induced intestinal damage. J Pharmacol Exp Ther. 2001;300:754–60.CrossRef
28.
go back to reference Takeuchi K, Tanaka A, Hayashi Y, Kubo Y. Functional mechanism underlying COX-2 expression following administration of indomethacin in rat stomachs: importance of gastric hypermotility. Dig Dis Sci. 2004;49:180–7.CrossRefPubMed Takeuchi K, Tanaka A, Hayashi Y, Kubo Y. Functional mechanism underlying COX-2 expression following administration of indomethacin in rat stomachs: importance of gastric hypermotility. Dig Dis Sci. 2004;49:180–7.CrossRefPubMed
29.
go back to reference Miura S, Tatsuguchi A, Wada K, Takeyama H, Shinji Y, Hiratsuka T, et al. Cyclooxygenase-2-regulated vascular endothelial growth factor release in gastric fibroblasts. Am J Physiol Gastrointest Liver Physiol. 2004;287:G444–51.CrossRefPubMed Miura S, Tatsuguchi A, Wada K, Takeyama H, Shinji Y, Hiratsuka T, et al. Cyclooxygenase-2-regulated vascular endothelial growth factor release in gastric fibroblasts. Am J Physiol Gastrointest Liver Physiol. 2004;287:G444–51.CrossRefPubMed
31.
go back to reference Takeuchi K, Matsuumoto J, Ueshima K, Okabe S. Role of capsaicin-sensitive afferent neurons in alkaline secretory response to luminal acid in the rat duodenum. Gastroenterology. 1991;101:954–61.PubMed Takeuchi K, Matsuumoto J, Ueshima K, Okabe S. Role of capsaicin-sensitive afferent neurons in alkaline secretory response to luminal acid in the rat duodenum. Gastroenterology. 1991;101:954–61.PubMed
32.
go back to reference Ohno T, Hattori Y, Komine R, Mizuguchi S, Arai K, Saeki T, et al. Roles of calcitonin gene-related peptide in maintenance of gastric mucosal integrity and in enhancement of ulcer healing and angiogenesis. Gastroenterology. 2008;134:215–25.CrossRefPubMed Ohno T, Hattori Y, Komine R, Mizuguchi S, Arai K, Saeki T, et al. Roles of calcitonin gene-related peptide in maintenance of gastric mucosal integrity and in enhancement of ulcer healing and angiogenesis. Gastroenterology. 2008;134:215–25.CrossRefPubMed
33.
go back to reference Lempinen M, Inkinen K, Wolff H, Ahonen J. Matrix metalloproteinases 2 and 9 in indomethacin-induced rat gastric ulcer. Eur Surg Res. 2000;32:169–76.CrossRefPubMed Lempinen M, Inkinen K, Wolff H, Ahonen J. Matrix metalloproteinases 2 and 9 in indomethacin-induced rat gastric ulcer. Eur Surg Res. 2000;32:169–76.CrossRefPubMed
34.
go back to reference Koolwijk P, van Erck MG, de Vree WJ, Vermeer MA, Weich HA, Hanemaaijer R, et al. Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity. J Cell Biol. 1996;132:1177–88.CrossRefPubMed Koolwijk P, van Erck MG, de Vree WJ, Vermeer MA, Weich HA, Hanemaaijer R, et al. Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity. J Cell Biol. 1996;132:1177–88.CrossRefPubMed
35.
go back to reference Zahner G, Harendza S, Müller E, Wolf G, Thaiss F, Stahl RA. Prostaglandin E2 stimulates expression of matrix metalloproteinase 2 in cultured rat mesangial cells. Kidney Int. 1997;51:1116–23.CrossRefPubMed Zahner G, Harendza S, Müller E, Wolf G, Thaiss F, Stahl RA. Prostaglandin E2 stimulates expression of matrix metalloproteinase 2 in cultured rat mesangial cells. Kidney Int. 1997;51:1116–23.CrossRefPubMed
36.
go back to reference Calabro A, Grappone C, Pellegrini G, Evangelista S, Tramontana M, Schuppan D, et al. Spatial and temporal pattern of expression of interstitial collagenase, stromelysin/transin, gelatinase A and TIMP-1 during experimental gastric ulcer healing. Digestion. 2004;70:127–38.CrossRefPubMed Calabro A, Grappone C, Pellegrini G, Evangelista S, Tramontana M, Schuppan D, et al. Spatial and temporal pattern of expression of interstitial collagenase, stromelysin/transin, gelatinase A and TIMP-1 during experimental gastric ulcer healing. Digestion. 2004;70:127–38.CrossRefPubMed
37.
go back to reference Tatsuguchi A, Fukuda Y, Ishizaki M, Yamanaka N. Localization of matrix metalloproteinases and tissue inhibitor of metalloproteinases-2 in normal human and rabbit stomachs. Digestion. 1999;60:246–54.CrossRefPubMed Tatsuguchi A, Fukuda Y, Ishizaki M, Yamanaka N. Localization of matrix metalloproteinases and tissue inhibitor of metalloproteinases-2 in normal human and rabbit stomachs. Digestion. 1999;60:246–54.CrossRefPubMed
Metadata
Title
Effects of lansoprazole on the expression of VEGF and cellular proliferation in a rat model of acetic acid-induced gastric ulcer
Authors
Shun Kobayashi
Noriko Nakajima
Yoko Ito
Mitsuhiko Moriyama
Publication date
01-08-2010
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 8/2010
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-010-0224-6

Other articles of this Issue 8/2010

Journal of Gastroenterology 8/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine